InvestorsHub Logo
Followers 1055
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

Re: None

Wednesday, 11/15/2017 2:53:54 AM

Wednesday, November 15, 2017 2:53:54 AM

Post# of 97237
NURO highly recommended a strong watch. Any positive development might have massively affect due to tiny cap($4m), cash on hand ( $4m cash per 10Q+ recently closed private $3.5M capital raise) and almost Zero debt.

Commercial stage. their new Quell product from AMZN 5 stars review.. https://www.amazon.com/Quell-Wearable-Relief-Technology-Starter/dp/B075YVCLZT/ref=dp_ob_image_def#customerReviews

9 transactions since June 2017, ALL Purchases VS zero Sales. https://www.insidermonkey.com/insider-trading/company/neurometrix+inc/1289850/purchases/

Catalysts:

1. There are currently 4 studies underway. http://www.businesswire.com/news/home/20170623005385/en/NeuroMetrix-Update-Quell-Wearable-Pain-Relief-Clinical

2. "third generation Quell platform..expect to launch in 2018" http://investor.neurometrix.com/releasedetail.cfm?ReleaseID=1044503




My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.